Delivery Order SPE2DX22D0010-SPE2D825FCC09

Award Date 12/23/24
Potential Completion Date 12/24/24
Potential Value $1.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FCC09
    Delivery Order

The federal contract award, with ID SPE2DX22D0010|SPE2D825FCC09, was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,108.47 Firm Fixed Price contract is for the delivery of XTAMPZA ER CAPS 18MG. This contract is not designated as a set-aside. The award is a Delivery Order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 3/24/25, 9:55 AM